We are live on ! Find out more
PPBT

Purple Biotech
PPBT

16 hedge funds and large institutions have $75.9K invested in Purple Biotech in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

0.29% less ownership

Funds ownership: 0.44% → 0.15% (-0.29%)

43% less capital invested

Capital invested by funds: $134K → $75.9K (-$57.8K)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$87.8K
2
Citadel Advisors
Citadel Advisors
Florida
+$74K
3
GI
GAMMA Investing
California
+$14.7K
4
Morgan Stanley
Morgan Stanley
New York
+$11.7K
5
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$8.97K

Top Sellers

Rank Fund Capital Flow
1
KWA
Kingswood Wealth Advisors
California
-$39.4K
2
UBS Group
UBS Group
Switzerland
-$30.8K
3
Raymond James Financial
Raymond James Financial
Florida
-$1.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$28K +$87.8K +4,899 New
Citadel Advisors
2
Citadel Advisors
Florida
$23.5K +$74K +4,126 New
GI
3
GAMMA Investing
California
$7.27K +$14.7K +822 +186%
BNP Paribas Financial Markets
4
BNP Paribas Financial Markets
France
$6.47K +$8.97K +500 +80%
Morgan Stanley
5
Morgan Stanley
New York
$6.36K +$11.7K +650 +142%
UBS Group
6
UBS Group
Switzerland
$3.41K -$30.8K -1,719 -74%
RhumbLine Advisers
7
RhumbLine Advisers
Massachusetts
$614 – – –
TCM
8
Tradewinds Capital Management
Washington
$58 +$179 +10 New
ASN
9
Advisory Services Network
Georgia
$57 +$179 +10 New
Northwestern Mutual Wealth Management
10
Northwestern Mutual Wealth Management
Wisconsin
$49 – – –
EWA
11
EverSource Wealth Advisors
Alabama
$32 +$72 +4 +200%
SS
12
SBI Securities
Japan
$11 – – –
GRP
13
Global Retirement Partners
California
$9 – – –
NSIM
14
North Star Investment Management
Illinois
$9 – – –
KWA
15
Kingswood Wealth Advisors
California
– -$39.4K -1,680 Closed
Raymond James Financial
16
Raymond James Financial
Florida
– -$1.3K -56 Closed
Simplex Trading
17
Simplex Trading
Illinois
– +$197 +11 +220%

PPBT Hedge Fund Activity: Q3 2025 in Review

16 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q3 2025, worth a combined $75.9K — down 43% from $134K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PPBT positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $87.8K. The largest seller was Kingswood Wealth Advisors, exiting entirely with an estimated $39.4K sold.

  • 16 institutional investors held Purple Biotech (PPBT) as of Q3 2025, up from 14 in Q2 2025.
  • Funds reported $75.9K of Purple Biotech stock for Q3 2025, down 43% quarter-over-quarter.
  • 4 funds opened new Purple Biotech positions in Q3 2025 and 2 closed out, a net change of +2 holders.
  • The largest Purple Biotech buyer in Q3 2025 was Virtu Financial, an estimated $87.8K added.
  • The largest Purple Biotech seller in Q3 2025 was Kingswood Wealth Advisors, an estimated $39.4K sold.

Based on aggregated 13F filings for Q3 2025.